Human albumin therapy of acute ischemic stroke: Marked neuroprotective efficacy at moderate doses and with a broad therapeutic window

Stroke

Volumn 32, Issue 2, 2001, Pages 553-560

  Belayev, Ludmila ^a   Liu, Yitao ^a   Zhao, Weizhao ^a   Busto, Raul ^a   Ginsberg, Myron D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Brain edema; Cerebral ischemia; Focal; Hemodilution; Middle cerebral artery occlusion; Neuroprotection

Indexed keywords

HUMAN ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN FUNCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HEMODILUTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035133027     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.2.553     Document Type: Article

References (53)

1. Epidemiology of stroke
2. Tissue plasminogen activator for acute ischemic stroke
3. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study
4. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience
5. Review. Cell damage in the brain: A speculative synthesis
6. Neurological progress: Viability thresholds and the penumbra of focal ischemia
7. Excitotoxic cell death
8. The central role of calcium ions and calcium-permeable channels in ischemic brain injury
9. Role of oxidants in ischemic brain damage
10. The role of cytokines in the neuropathology of stroke and neurotrauma
11. Emerging treatments for stroke in humans
12. The changing landscape of ischaemic brain injury mechanisms
13. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats
14. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia
15. The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats
16. Middle cerebral artery occlusion in the rat by intraluminal suture: Neurological and pathological evaluation of an improved model
17. The Cortex of the Rat
18. Depiction of infarct frequency distribution by computer-assisted image mapping in rat brains with middle cerebral artery occlusion: Comparison of photothrombotic and intraluminal suture models
19. Protein extravasation and cellular uptake after high-dose human-albumin treatment of transient focal cerebral ischemia in rats
20. Neuroprotective effect of high-dose albumin therapy against global ischemic brain injury in rats
21. Post-treatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats
22. The antioxidants of human extracellular fluids
23. Intracranial and systemic effects of osmotic and oncotic therapy in experimental cerebral edema
24. Effect of oncotic pressure of diaspirin cross-linked hemoglobin (DCLHb) on brain injury after temporary focal cerebral ischemia in rats
25. Comparison of crystalloids and colloids for hemodilution in a model of focal cerebral ischemia
26. Hydroxyethyl starch 200/0.5 reduces infarct volume after embolic stroke in rats
27. Optimal timing of hemodilution for brain protection in a canine model of focal cerebral ischemia
28. Beneficial effect of prolonged administration of albumin on ischemic cerebral edema and infarction after occlusion of middle cerebral artery in rats
29. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites
30. Drag therapy, II: Binding of drags to serum albumin
31. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation: The important contribution made by plasma proteins
32. i
33. Albumin modulation of capillary permeability: Test of an adsorption mechanism
34. Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins: Presence in many cells and tissues with a possible role in catabolism
35. Albumin affects erythrocyte aggregation and sedimentation
36. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells
37. Regional brain sodium, potassium, and water changes in the rat middle cerebral artery occlusion model of ischemia
38. Brain edema and cerebrovascular permeability during cerebral ischemia in rats
39. Protein and electrolyte changes in experimental cerebral edema
40. Long-term high-colloid oncotic therapy for ischemic brain edema in gerbils
41. Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes
42. 2+ concentrations but by free-fatty acid sequestration
43. Postischemic inhibition of cerebral cortex pyruvate dehydrogenase
44. Multicenter trial of hemodilution in acute ischemic stroke: Results of subgroup analyses
45. Haemodilution in acute stroke: Results of the Italian haemodilution trial
46. Hypervolemic hemodilution treatment of acute stroke: Results of a randomized multicenter trial using pentastarch: The Hemodilution in Stroke Study Group
47. Hypervolemic hemodilution in acute ischemic stroke: The Multicenter Austrian Hemodilution Stroke Trial (MAHST)
48. Custom-tailored hemodilution with albumin crystalloids in acute ischemic stroke
49. Hemorheological hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage
50. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: A randomized controlled trial
51. High colloid oncotic therapy for contusional brain edema
52. High colloid oncotic therapy for brain edema with cerebral hemorrhage
53. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis